Antibodies to C5a have proven to be effective in treating experimental septic primate models [1, 2] .
Antibodies to C5a have proven to be effective in treating experimental septic primate models [1, 2] .
A 17 amino acid peptide (ASGAPAPGPAGPLRPMF) named PepA binds to C5a and prevents complement-mediated lethal shock in rats [3] .
AcPepA harboring an acetyl group at the N-terminal alanine showed increased inhibitory activity against C5a [4] .
Cynomolgus monkeys destined to expire from alethal dose of bacterial endotoxin (4mg/kg) were rescued by intravenous administration of AcPepA. AcPepA could have interfered with the ability of C5a to stimulate C5L2 [5, 6] which is responsible for HMGB1 release and stimulation of TLR4 [7] [8] [9] as an endogeneous ligand with LPS behavior. The suppression of HMGB1 release by AcPepA administration to LPS-shock monkeys is likely responsible for rescuing the animals. Sepsis is a systemic inflammatory response syndrome (SIRS) that causes disseminated intravascular coagulation (DIC) and multiple organ failure (MOF). Antibodies to C5a have proven to be effective in treating experimental septic primate models 1, 2. We generated an inhibitory peptide of C5a composed of an amino acid sequence ASGAPAPGPAGPLRPMF named PepA3. Acetylation at the N-terminal alanine of PepA improved the C5a inhibitory capacity and was named AcPepA4.
Under anesthesia with sodium pentobarbital, 10 cynomolgus monkeys (weighing about 5 kg) were intravenously administered 4 mg/kg LPS within 30 min. Three monkeys for the control group were infused with 15 ml saline during 3 hrs after the LPS injection. Seven experimental group monkeys were infused intravenously with 15 ml of 2 mg/ml AcPepA starting at 30 min after LPS injection for 3 hrs (2 mg/kg/hr for 3 hrs). Six hrs after LPS administration, anesthesia was terminated when the blood samples showed leukocytosis and increased CPK in all monkeys. Monkeys were observed for their status. All of the 7 AcPepA treated monkeys returned to a healthy condition by the following day, while the 3 control monkeys died within two days.
Despite the increased TNF and other cytokine levels, high mobility group box 1 (HMGB1) [5, 6] which is an endogenous stimulator of TLR47-9 did not increase in the AcPepA infused animals (Figure 1 ).
Furthermore, AcPepA could suppress pathophysiological events and prolonged survival time of sepsis piglets induced by cecal ligation and perforation (CLP) [10] . Survival times were longer in the AcPepA treated group than in the CLP alone group (19.3hrs ± 2.7hrs vs. 9.9 hrs ± 0.7 hrs, P<0.005). In this case, AcPepA also delayed the HMGB-1 surge. These above results indicate that suppression of C5 anaphylatoxin interferes with the induction of a cytokine storm. Since C5a has the capacity to cause release of HMGB1 following stimulation of the second C5a receptor termed C5L2 generated on activated monocytes [11] [12] [13] , inhibition of C5a successfully interferes with the above release which has the capacity to generate inflammatory cytokines stimulating TLR4 as an endogenous ligand (Figure 2 ). The enhanced activity of thrombin when complexed with TM should have caused activation of thrombin activatable fibrinolysis inhibitor (TAFI) which then inactivates C5a anaphylatoxin by removing the C terminal arginine [15, 16] resulting in suppression of HMGB1 release. Therefore, the therapeutic effect of TM on sepsis should also be due to inactivation of C5a anaphylatoxin which initiates a cytokine storm through HMGB1 release.
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